MEDICAID: Provides relative to the Medicaid Pharmaceutical and Therapeutics Committee

HB 927 modifies Louisiana's Medicaid Pharmaceutical and Therapeutics Committee by requiring one physician or pharmacist from each Medicaid managed care organization (MCO) to serve on the committee. It also removes prior restrictions on HIV/AIDS medications that previously limited their coverage under Medicaid. The bill directly affects Medicaid managed care organizations, their healthcare providers, and Medicaid patients who use pharmaceuticals. These changes aim to improve committee representation and expand access to HIV/AIDS treatments within the state's Medicaid program.